Jensen Quality Growth ETF
JGRW
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 5500 Meadows Road, Suite 200 Lake Oswego OR United States of America 97035
- IPO Date
- Aug 13, 2024
- Website
- jenseninvestment.com
- Similar Companies
- Business
- Jensen Quality Growth ETF (JGRW) is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing in a concentrated portfolio of 25 to 30 U.S. large-cap equities exhibiting high quality and sustainable growth characteristics, including consistent returns on equity of at least 15% over the prior 10 years, strong financial condition, and competitive advantages; the fund emphasizes sectors such as information technology (approximately 39%), health care (17%), industrials (18%), and financials (11%), with top holdings including Microsoft Corp., Stryker Corp., Marsh & McLennan Companies Inc., Intuit Inc., and Apple Inc. Launched on August 13, 2024, and domiciled in the United States, JGRW trades on the NYSE Arca exchange with an annual expense ratio of 0.57% and is advised by Jensen Investment Management, headquartered in Lake Oswego, Oregon; the fund is issued by the Trust for Professional Managers and distributed by Foreside Fund Services, LLC, targeting long-term investors seeking growth with lower volatility than the broader market. In its inaugural year through July 31, 2025, JGRW grew to total net assets of approximately $69 million, reflecting steady adoption by institutional investors including SOL Capital Management CO, HighTower Advisors, LLC, and Captrust Financial Advisors. During the second quarter of 2025, the investment team initiated new positions in NVIDIA Corp., Eli Lilly and Co., and Meta Platforms Inc. to enhance exposure to high-growth opportunities in AI, pharmaceuticals, and social media, while exiting holdings in Nike Inc., Texas Instruments Inc., PepsiCo Inc., and UnitedHealth Group Inc. due to diminished conviction amid supply chain challenges, sector volatility, GLP-1 drug impacts, and rising medical costs. These portfolio adjustments underscore a strategic upgrade to the fund's quality and growth profile amid market volatility and tariff-related turbulence, maintaining an active share of 72% relative to the S&P 500 Index benchmark.